Clinical OMICs empowers healthcare professionals to harness the application of molecular-based
technologies to transform patient care through a combination of news, contributed articles, and expert analysis.
Pharmacogenetics experts establish common vocabulary in a ?bid to advance precision medicine initiatives.
New research has revealed an unexpected drug resistance mechanism that bypasses the need to re-establish DNA damage repair in breast cancer.
We will explore how liquid biopsies are shaping the diagnostic landscape and how it will impact physician decision making and patient care.
2015 was a phenomenal year full of new developments for the structures and mechanisms of CRISPR systems.